BOROSCI

Borosil Scientific Share Price

₹158.64 +0.17 (0.11%)

14 Jul, 2025 12:14

SIP TrendupStart SIP in BOROSCI

Start SIP

Performance

  • Low
  • ₹156
  • High
  • ₹164
  • 52 Week Low
  • ₹107
  • 52 Week High
  • ₹223
  • Open Price₹158
  • Previous Close₹158
  • Volume134,644

Investment Returns

  • Over 1 Month + 12.51%
  • Over 3 Month + 26.27%
  • Over 6 Month + 3.68%
  • Over 1 Year -19.52%
SIP Lightning

Smart Investing Starts Here Start SIP with Borosil Scientific for Steady Growth!

Invest Now

Borosil Scientific Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 52.6
  • PEG Ratio
  • 3.8
  • Market Cap Cr
  • 1,411
  • P/B Ratio
  • 3.6
  • Average True Range
  • 6.87
  • EPS
  • 3.01
  • Dividend Yield
  • 0
  • MACD Signal
  • 5.72
  • RSI
  • 56.26
  • MFI
  • 75.35

Borosil Scientific Financials

Borosil Scientific Technicals

EMA & SMA

Current Price
₹158.64
+ 0.17 (0.11%)
pointer
  • stock-down_img
  • Bearish Moving Average 5
  • stock-up_img
  • Bullish Moving Average 11
  • 20 Day
  • ₹156.72
  • 50 Day
  • ₹148.62
  • 100 Day
  • ₹146.85
  • 200 Day
  • ₹157.93

Resistance and Support

158.79 Pivot Speed
  • R3 167.80
  • R2 164.90
  • R1 161.69
  • S1 155.58
  • S2 152.68
  • S3 149.47

What's your outlook on Borosil Scientific?

You can only vote once!

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Borosil Scientific specializes in manufacturing laboratory glassware, scientific instruments, and precision equipment. The company serves industries like pharmaceuticals, research, and education, providing high-quality products for scientific research and testing in domestic and international markets.

Borosil Scientific Ltd has an operating revenue of Rs. 437.75 Cr. on a trailing 12-month basis. An annual revenue growth of 12% is good, Pre-tax margin of 9% is okay, ROE of 6% is fair but needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading close to its 200DMA and around 11% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 64 which is a FAIR score but needs to improve its earnings, a RS Rating of 63 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 170 indicates it belongs to a poor industry group of Medical-Research Eqp/Svc and a Master Score of B is close to being the best. Overall, the stock definitely has some strength, you may want to examine it in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Borosil Scientific Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-05-21 Audited Results & Others Inter-alia, to consider 1. Seek shareholders approval (through an enabling resolution) for raising of funds through various modes, further public offer, debt issuance or any other method.
2025-02-11 Quarterly Results
2024-11-12 Quarterly Results
2024-08-13 Quarterly Results

Borosil Scientific F&O

Borosil Scientific Shareholding Pattern

67.82%
0.01%
0.24%
0%
22.88%
9.05%

About Borosil Scientific

  • NSE Symbol
  • BOROSCI
  • BSE Symbol
  • 544184
  • ISIN
  • INE02L001032

Similar Stocks to Borosil Scientific

Borosil Scientific FAQs

Borosil Scientific share price is ₹158 As on 14 July, 2025 | 12:00

The Market Cap of Borosil Scientific is ₹1411 Cr As on 14 July, 2025 | 12:00

The P/E ratio of Borosil Scientific is 52.6 As on 14 July, 2025 | 12:00

The PB ratio of Borosil Scientific is 3.6 As on 14 July, 2025 | 12:00

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23